Mouse Anti-Human Ankyrin G Monoclonal IgG1 Antibody
Ankyrin-G (ANK3) is a critical scaffolding protein that anchors integral membrane proteins to the spectrin-actin cytoskeleton, ensuring the structural and functional integrity of excitable cells, particularly neurons. It binds to the β-spectrin subunit and a wide array of membrane proteins, including voltage-gated sodium channels, potassium channels, and cell adhesion molecules, orchestrating their precise localization at the axon initial segment (AIS) and nodes of Ranvier.
In the central nervous system, Ankyrin-G plays a pivotal role in maintaining neuronal polarity, regulating action potential initiation, and preserving synaptic stability. Disruption of Ankyrin-G function leads to mislocalization of ion channels and cytoskeletal disorganization, contributing to impaired neuronal signaling.
Emerging evidence links ANK3 mutations and dysregulation to a spectrum of neuropsychiatric and neurodegenerative disorders, including bipolar disorder, schizophrenia, epilepsy, and Alzheimer’s disease. In Alzheimer’s models, Ankyrin-G dysfunction has been associated with AIS disassembly and increased neuronal vulnerability, suggesting a mechanistic link between cytoskeletal breakdown and neurodegeneration.
Given its central role in neuronal architecture and excitability, Ankyrin-G is increasingly recognized as a potential biomarker and therapeutic target in neurodegenerative disease research. Understanding its molecular interactions and regulatory mechanisms is essential for developing strategies to preserve neuronal function and prevent disease progression.
This Mouse Anti-Human Ankyrin G Monoclonal IgG1 Antibody is manufactured in Canada by StressMarq.
